Stock comparison
Aveanna Healthcare Holdings
Haemonetics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AVAH
Aveanna Healthcare Holdings
Market cap
$1.6B
Sector
Healthcare
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
Overall winner
Haemonetics HAE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AVAH | HAE | Winner |
|---|---|---|---|
| Warren Buffett | 38D | 70B | HAE |
| Benjamin Graham | 57D | 85A | HAE |
| Philip Fisher | 35D | 60C | HAE |
| Peter Lynch | 69B | 54C | AVAH |
| Joel Greenblatt | 46D | 31F | AVAH |
| Charlie Munger | 42D | 54D | HAE |
| Terry Smith | 31F | 55D | HAE |
Side-by-side metrics
| Metric | AVAH | HAE |
|---|---|---|
| Market cap | $1.6B | $2.98B |
| P/E (TTM) | 6.3x | 24.8x |
| EV/EBIT | 11.3x | 14.1x |
| ROIC (TTM) | 15.86% | 8.37% |
| Gross margin | 32.67% | 55.74% |
| Net margin | 10.37% | 7.29% |
| Revenue CAGR 5y | 9.73% | 7.65% |
| EPS CAGR 5y | - | 24.62% |
| Debt / Equity | 6.3x | 1.5x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AVAH leads on
- P/E (TTM)6.3xvs 24.8x+75%
- ROIC (TTM)15.86%vs 8.37%+47%
- Net margin10.37%vs 7.29%+30%
- Revenue CAGR 5y9.73%vs 7.65%+21%
HAE leads on
- Debt / Equity1.5xvs 6.3x+75%
- Market cap$2.98Bvs $1.6B+46%
- Gross margin55.74%vs 32.67%+41%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.